OTC Markets Group uses cookies and similar technologies to help us understand how you use our websites, as further disclosed in our Privacy Policy. Our Terms of Service contain important information including restrictions on your use of our websites. By clicking “Accept”, or by continuing to use our websites, you consent to the use of cookies and agree to the terms of the OTC Markets Group Privacy Policy and Terms of Service.
RDGL
Vivos Inc.
0.1188
-0.00062
-0.52%
0.0959 / 0.1437 (10000 x 5000)
Vivos Inc.
1030 N Center Parkway
Kennewick, WA 99336
1030 N Center Parkway
Kennewick, WA 99336
None
802 N. Washington St.
Spokane, WA 99201
655 West Broadway, Suite 870
San Diego, CA 92101
The products are IsoPet© for animal therapy and RadioGel© for future human therapy. They are Yttrium-90 beta emitter devices. The solutions are injected into the tumor and the hydrogel component gels upon reaching body temperature. This locks in the Y-90 phosphate particles to deliver very high local doses. It is a same day therapy that delivers a high local dose with insignificant co-lateral damage to healthy organs.
The Y-90 isotope is produced in Massachusetts. The RadioGel© is manufactured in Texas. There are currently fifteen certified clinics for IsoPet© Therapy across the United States and a human clinical trial at the Health Care Global Hospital (HCG) in Bangalore, India.
